Faculty of Medicine, McGill University, Montreal, Canada.
Department of Otolaryngology-Head & Neck Surgery, McGill University, Montreal, Canada.
Am J Rhinol Allergy. 2023 Sep;37(5):593-610. doi: 10.1177/19458924231177854. Epub 2023 May 25.
Positron emission tomography (PET) scan is a valuable imaging modality widely used in the management of cancers. Its usage is well defined for most head and neck malignancies. However, there is a lack of consensus regarding the utility of PET scan for sinonasal malignancies. This is highlighted by the latest international consensus statement on endoscopic skull base surgery.
This systematic review aims to clarify the role of PET scan in the management of sinonasal malignancies.
We conducted a comprehensive literature search using PubMed, MEDLINE, EMBASE, Web of Science, CINAHL, and Cochrane databases for research studies of interest. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) updated statement was used to guide the review.
In total, 1807 articles were assessed for eligibility. Thirty-nine original papers, published between 2004 and 2021, met inclusion criteria. Seven articles focused on the role of PET scan for inverted papilloma, 23 for sinonasal carcinoma, 4 for melanoma, and 3 for lymphoma, and finally, 3 articles focused on the use of specific PET scan tracers for sinonasal malignancies. Qualitative summaries for each potential role of PET scans were provided. In general, included studies were retrospective in nature with low level of evidence.
In general, and across all types of sinonasal malignancies, PET scan yielded positive results regarding detection and initial staging. It was also considered as the modality of choice for detection of distant metastases, except in the case of sinonasal lymphoma. PET scan's main limit resides in its inability to detect lesions in or close to the metabolic activity of the brain.
正电子发射断层扫描(PET)是一种广泛应用于癌症管理的有价值的成像方式。它在大多数头颈部恶性肿瘤中的应用已得到明确界定。然而,对于鼻窦恶性肿瘤,PET 扫描的效用尚未达成共识。这一点在最新的内镜颅底外科国际共识声明中得到了强调。
本系统评价旨在阐明 PET 扫描在鼻窦恶性肿瘤管理中的作用。
我们使用 PubMed、MEDLINE、EMBASE、Web of Science、CINAHL 和 Cochrane 数据库进行了全面的文献检索,以寻找相关的研究。我们使用经过更新的《系统评价和荟萃分析的首选报告项目》(PRISMA)声明来指导综述。
共有 1807 篇文章被评估是否符合纳入标准。最终,39 篇原始文章,发表于 2004 年至 2021 年期间,符合纳入标准。其中 7 篇文章聚焦于 PET 扫描在 inverted papilloma 中的作用,23 篇聚焦于 sinonasal carcinoma,4 篇聚焦于黑色素瘤,3 篇聚焦于淋巴瘤,最后 3 篇文章则关注了特定的 PET 扫描示踪剂在鼻窦恶性肿瘤中的应用。我们对每个潜在的 PET 扫描作用提供了定性总结。总体而言,纳入的研究主要是回顾性的,证据水平较低。
一般来说,对于所有类型的鼻窦恶性肿瘤,PET 扫描在检测和初始分期方面都取得了阳性结果。它也被认为是检测远处转移的首选方式,除了鼻窦淋巴瘤。PET 扫描的主要局限性在于其无法检测到靠近或处于代谢活跃的大脑的病变。